Gene · 1844
Papers2,214
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,214
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Research progress of stationary phase of gas chromatography based on chiral organic frameworks]. | Se Pu | 2024 | 38197202 | PubTator, text mining | PubMed |
| Platelets from patients with chronic inflammation have a phenotype of chronic IL-1β release. | Res Pract Thromb Haemost | 2024 | 38192728 | PubTator, text mining | PubMed |
| Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphoma. | Exp Hematol Oncol | 2024 | 38173015 | PubTator, text mining | PubMed |
| Characteristics of the a sequence of the duck Plague virus genome and specific cleavage of the viral genome based on the a sequence. | Vet Res | 2024 | 38172999 | PubTator, text mining | PubMed |
| Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38172098 | PubTator, text mining | PubMed |
| Toll-like receptor expression and functional behavior in platelets from patients with systemic lupus erythematosus. | Immunobiology | 2024 | 38159527 | PubTator, text mining | PubMed |
| Investigation of the role of von Willebrand factor in shear-induced platelet activation and functional alteration under high non-physiological shear stress. | Artif Organs | 2024 | 38112069 | PubTator, text mining | PubMed |
| Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes. | J Clin Oncol | 2024 | 38055913 | PubTator, text mining | PubMed |
| Adhesive properties of plasma-circulating and platelet-derived microvesicles from healthy individuals. | Thromb Res | 2024 | 38039724 | PubTator, text mining | PubMed |
| Single‑cell sequencing, genetics, and epigenetics reveal mesenchymal stem cell senescence in osteoarthritis (Review). | Int J Mol Med | 2024 | 37937669 | PubTator, text mining | PubMed |
| Complexation of histone deacetylase inhibitor belinostat to Cu(II) prevents premature metabolic inactivation in vitro and demonstrates potent anti-cancer activity in vitro and ex vivo in colon cancer. | Cell Oncol (Dordr) | 2024 | 37934338 | PubTator, text mining | PubMed |
| LIS1 (Pac1) binding slows dissociation of dynein from microtubules. | Nat Chem Biol | 2024 | 37932530 | PubTator, text mining | PubMed |
| Suppressed transcript diversity and immune response in COVID-19 ICU patients: a longitudinal study. | Life Sci Alliance | 2024 | 37918965 | PubTator, text mining | PubMed |
| Perspective from single-cell sequencing: Is inflammation in acute ischemic stroke beneficial or detrimental? | CNS Neurosci Ther | 2024 | 37905592 | PubTator, text mining | PubMed |
| An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed. | Front Cardiovasc Med | 2023 | 38179503 | PubTator, text mining | PubMed |
| Ubiquitin signaling in pancreatic ductal adenocarcinoma. | Front Mol Biosci | 2023 | 38174069 | PubTator, text mining | PubMed |
| Prospect of Exosome in Ligament Healing: A Systematical Review. | Stem Cells Cloning | 2023 | 38162837 | PubTator, text mining | PubMed |
| Case Report: CD19 CAR T-cell therapy following autologous stem cell transplantation: a successful treatment for R/R CD20-negative transformed follicular lymphoma with TP53 mutation. | Front Immunol | 2023 | 38143763 | PubTator, text mining | PubMed |
| Dual-Specificity Phosphatases in Regulation of Tumor-Associated Macrophage Activity. | Int J Mol Sci | 2023 | 38139370 | PubTator, text mining | PubMed |
| ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming. | Toxins (Basel) | 2023 | 38133177 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1844/papers?page=8